Common Professional Services SOAR-NIAID-210617-1 recompete

This request is to recompete SOAR-NIAID-210617 (9/13/26-9/12/26). This request is directly related to Task Order NIAID-210617-1 responsibilities to prepare and distribute important infectious disease documentation to NIAID and the extramural research community to ensure compliance with Federal policies - 1 Health Specialist FTE. The Task Order NIAID-210617-1 position fills a critical and unique role working directly with the Division's clinical team to disseminate clinical research policies and requirements to protect health and human life. The clinical team has created an extensive inventory of these materials, which inform the planning and conduct of trials supported through NIAID's Division of Microbiology and Infectious Diseases (DMID). The position independently manages the process to share these vitally important resources with the scientific community, a critical component of DMID's efforts to ensure that investigator-initiated clinical trials protect patient safety and are conducted in compliance with federal requirements. Related, this position responds to time sensitive requests to prepare documentation for NIH Leadership describing the Division's clinical trial research activities and compliance with recently implemented policies.

In addition, the Task Order NIAID-210617-1 position leads trans-NIAID collaborations to create vital resources for infectious disease product developers who are advancing new medical countermeasures to protect human health and benefit the American people. These countermeasures address a wide range of public health concerns, including antimicrobial resistance (AMR) and biodefense threats . The position directs implementation of strategies to increase transparency of NIAID programs to support product developers, expand the pipeline of therapeutics, preventives, and diagnostics to strengthen U.S. preparedness against infectious disease threats. The Task Order NIAID-210617-1 position is able to leverage extensive expertise in AMR to support senior leadership and U.S. government efforts to address the concerning prevalence of healthcare-associated and community-acquired infections, which threaten human health and progress made against chronic diseases. If this request is not approved, there will be delays with distribution of critical information regarding the conduct and implementation of clinical trials. Key resources to support researchers developing new and improved tools to treat, prevent, and diagnose infectious diseases will also be delayed.